Finance

Lists
Why is OSE up 2.68%?
Dive Deeper
OSE:EPA
Ose Immunotherapeutics SA
€2.30
+2.68%
(+0.060) 1D
Sep 28, 2:37:17 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
€2.22
High
€2.41
Low
€2.19
Mkt. cap
54.28M
Avg. vol.
123.63K
Volume
268.64K
52-wk high
€7.70
52-wk low
€2.19
EPS
-€1.69
Shares outstanding
23.56M
No. of employees
64
Open
€2.22
High
€2.41
Low
€2.19
Mkt. cap
54.28M
Avg. vol.
123.63K
Volume
268.64K
52-wk high
€7.70
52-wk low
€2.19
EPS
-€1.69
Shares outstanding
23.56M
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
FoundedNov 17, 2004
Headquarters-
SectorBiotechnology
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2024
Dec 2024
Revenue
431.00K
431.00K
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8.28M
8.28M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.08M
1.08M
Operating expense
10.22M
10.22M
Total operating expenses
10.22M
10.22M
Operating income
-9.79M
-9.79M
Other non operating income
-611.00K
-611.00K
EBT including unusual items
-10.44M
-10.44M
EBT excluding unusual items
-10.53M
-10.53M
Income tax expense
-576.50K
-576.50K
Effective tax rate
5.52%
5.52%
Other operating expenses
41.00K
41.00K
Net income
-9.86M
-9.86M
Net profit margin
-2,288.86%
-2,288.86%
Earnings per share
-
-
Interest and investment income
571.00K
571.00K
Interest expense
-707.50K
-707.50K
Net interest expenses
-136.50K
-136.50K
Depreciation and amortization charges
-
-
EBITDA
-9.74M
-9.74M
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps